-->

DentScribe Receives Notice of Allowance for U.S. Patent

Article Featured Image

DentScribe has received a notice of allowance from the U.S. Patent and Trademark Office (No. 18/593,903, titled "System, Method, and Apparatus for Automating Creation of Subjective, Objective, Assessment, and Plan (SOAP) Reports," validating the foundational inventions behind DentScribe's agentic AI technology to transform chairside conversations into structured clinical documentation and revenue-generating action.

The allowed claims protect a system that automates dental clinical documentation end-to-end, including the following:

  • Real-time operatory speech capture and transcription tuned for dentistry: including recognition of dental terminology such as tooth numbering schemes, periodontal charting terms, and orthodontic descriptors.
  • Structured clinical extraction using multiple parallel prompt modules: designed to extract standardized categories across the dental record (including periodontal findings, hard tissue findings, radiographic findings, orthodontic conditions, assessment, treatment plan, referrals, consent, and patient education) and aggregate them into a structured record.
  • Practice-specific Plan automation through template-to-CDT mapping: converting a practice's unstructured templates into a persistent mapping between CDT procedure codes and practice-specific procedural steps, then using that mapping to automatically populate the Plan section of the SOAP note.
  • PMS-native publishing: inserting the structured SOAP note directly into dental practice management systems using interfaces aligned to the PMS data model.
  • Automated chart review and opportunity surfacing: analyzing historical SOAP notes to detect unfinished, deferred, or overlooked treatments, generating a patient-specific checklist, and presenting it at the point of care.
  • Practice-wide daily operational dashboard: aggregating patient-level opportunities across the day's schedule into a dashboard segmented by provider, operatory, discipline, and production value tier to support morning huddles and daily execution.

"This notice of allowance is a landmark moment for DentScribe and for dental AI," said Dr. Vinni Singh, founder and CEO of DentScribe, in a staterment. "It validates the core inventions we built to do what dentistry actually needs: listen in real time, understand clinical context, produce structured SOAP documentation, and then convert that documentation into follow-up actions that improve care delivery and increase production. This is the foundation for DentScribe's agentic platform, where the chart doesn't just get written; it gets used. This gives DentScribe a sophisticated moat against competitors."

"Most systems capture words. This invention protects a system that captures clinical intent and operationalizes it," said Dr. Ratinder Paul Ahuja, board chair of DentScribe, in a statement. "As an inventor, I'm excited by the scope and rigor of what's been allowed: real-time, schema-driven clinical extraction, deterministic structuring, and a closed loop from documentation into decision support and daily operations. This is the kind of foundational innovation that will define the next decade of AI in dentistry."